Kumquat Biosciences Revenue

Biotechnology Research • San Diego, California, United States • 51-100 Employees

Kumquat Biosciences revenue & valuation

Annual revenue	$7,015,510
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$22,500,000
Total funding	$70,000,000

Key Contacts at Kumquat Biosciences

Tao Wu

Executive Director And Head Of Cmc

Lijun Duan

Director Of Analytical Development & Qc Cmc

Shaun Maceachern

Executive Director Clinical Supply Chain

Pingda Ren

Co-Founder, President/Coo

Darren Huber

Senior Director, Global Safety Officer

Caitlin Murphy

Director, Toxicology

Anna Harris

Director Clinical Operations

Shiva Safaei

Director, Regulatory Operations

Andrew Witt

Sr. Director, Quality Assurance

Chandrasekhar Garapati

Associate Director Drug Product

Company overview

Headquarters	3033 Science Park Rd, Suite 200, San Diego, California 92121, US
Phone number	+18585008870
Website	kumquatbiosciences.com
NAICS	541714
Employees	51-100
Socials

Kumquat Biosciences Email Formats

Kumquat Biosciences uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@kumquatbio.com), used 92.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@kumquatbio.com	92.6%
{first name}{last name}	johndoe@kumquatbio.com	5.9%
{first name}	john@kumquatbio.com	1.5%

About Kumquat Biosciences

Kumquat Biosciences’ vision is to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients. We are committed to translate breakthrough science to innovative medicines by combining internal expertise in drug discovery and development, with external collaboration with academics. Kumquat brings together an accomplished management team with proven track record in discovering and developing innovative oncology medicines. The founding team has previously co-founded Intellikine, Araxes/Wellspring Biosciences and Kura Oncology. Kumquat Biosciences currently focuses on multiple first-in-class programs including targeted therapy as well as immunotherapy. Kumquat is funded by leading biotech venture investors as well as a pharmaceutical corporate venture.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director

Entry

Senior

Employees by Department

Kumquat Biosciences has 36 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Kumquat Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-08-29	19	$70,000,000

Funding Insights

$70,000,000

Total funding amount

$70,000,000

Most recent funding amount

Number of funding rounds

Kumquat Biosciences Tech Stack

Discover the technologies and tools that power Kumquat Biosciences's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

GoDaddy

Hosting

PHP

Programming languages

WordPress

Blogs

WordPress Super Cache

Caching

Google Maps

Maps

MySQL

Databases

RSS

Miscellaneous

Microsoft 365

jQuery Migrate

JavaScript libraries

Frequently asked questions

Kumquat Biosciences is located in San Diego, California, US.

You can reach Kumquat Biosciences at +18585008870.

Kumquat Biosciences generates an estimated annual revenue of $7,015,510. This revenue figure reflects the company's market position and business performance in its industry.

Kumquat Biosciences has an estimated valuation of $22,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kumquat Biosciences has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Kumquat Biosciences has raised a total of $70,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.